Incorporation of Ruxolitinib in the Management of Refractory/Relapsed Hodgkin Lymphoma: Where Do We Stand?

ABSTRACT:

SUBMITTER: Al Sharie AH 

PROVIDER: S-EPMC10515879 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature